Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2005
08/25/2005WO2005077084A2 Krüppel-like transcriptional factor klf4/gklf and uses thereof
08/25/2005WO2005077072A2 Hybrid polypeptides with selectable properties
08/25/2005WO2005077044A2 Rational design and engineering of proteins and peptides for immunomodulation
08/25/2005WO2005077042A2 Albumin fusion proteins
08/25/2005WO2005077018A2 Methods of treating skin disorders
08/25/2005WO2005077003A2 Pili from mycobacterium tuberculosis
08/25/2005WO2005076972A2 Chimeric vegf peptides
08/25/2005WO2005076886A2 Prostasin substrates and inhibitors
08/25/2005WO2005076827A2 Fbsa compositions for use in promoting fibrinogen aggregation and potentiating fibrin polymerization
08/25/2005WO2005076786A2 Colon carcinoma related oligonucleotides and methods of use
08/25/2005WO2005076785A2 Method and compositions for detecting botulinum neurotoxin
08/25/2005WO2005065707A3 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof
08/25/2005WO2005059562A3 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases
08/25/2005WO2005059124A3 Isozyme-specific antagonists of protein kinase c
08/25/2005WO2005056584A3 Novel strain of sars-associated coronavirus and applications thereof
08/25/2005WO2005051995A3 Novel advanced glycosylation end product-specific receptor-like protein and nucleic acids encoding same
08/25/2005WO2005051991A3 Mucin antigen vaccine
08/25/2005WO2005047320A3 Equine p-selection glycoprotein ligand-1 and uses thereof
08/25/2005WO2005035771A3 Nucleic acid constructs
08/25/2005WO2005033134A3 Secreted protein therapeutics and uses thereof
08/25/2005WO2005027963A3 METHODS AND COMPOSITIONS FOR THE GENERATION OF A PROTECTIVE IMMUNE RESPONSE AGAINTS SARS-CoV
08/25/2005WO2005026208A3 Chimeric gabab receptor
08/25/2005WO2005021585B1 Axmi-003, a delta-endotoxin gene and methods for its use
08/25/2005WO2005019831A3 Methods for reducing complexity of a sample using small epitope antibodies
08/25/2005WO2005007829A3 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
08/25/2005WO2004113500A3 B7s1: an immune modulator
08/25/2005WO2004093820A3 Methods and compositions for solid tumor treatment
08/25/2005WO2004078203A9 Infectious bronchitis virus with an altered spike gene
08/25/2005WO2004067711A3 Peroxisome proliferator-activated receptor
08/25/2005WO2004043988A8 Ptprk immunogenic peptide
08/25/2005WO2004042071A3 Detection and typing of human papillomavirus using pna probes
08/25/2005US20050188442 Method for altering storage organ composition
08/25/2005US20050188441 Lipoxygenase polynucleotides and methods of use
08/25/2005US20050188440 Nucleotide sequences coding insect hemolymph polypeptide for use in generating disease resistant plants; microbiocides; biological pest control
08/25/2005US20050188438 Compositions and methods using rna interference for control of nematodes
08/25/2005US20050188433 Expression vector comprising nucleotide sequences coding succinate/fumarate-transport protein for use generating and propagating plants with enhanced germination behavior
08/25/2005US20050188429 Method for treating a condition with a cytokine of the GP130 subunit signaling family linked to a polynucleotide encoding SOCS-3
08/25/2005US20050188428 Method for generating hypermutable organisms
08/25/2005US20050187718 Novel purified polypeptides from Streptococcus pneumoniae
08/25/2005US20050187382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/25/2005US20050187379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/25/2005US20050187378 nucleotide sequences encoding oligopeptide sequences which can render fusion partner proteins environmental stress resistant by binding thereto while conserving their intrinsic properties; recombinant vectors, and cells transformed by them
08/25/2005US20050187179 treatment of tumors which have increased Notch expression; administration of either Notch antisense oligonucleotides or monoclonal antibodies directed to Notch along with cell differentiating agent
08/25/2005US20050187177 chimeric gene construct composed of a COX-2 promoter operably linked to at least one apoptosis-inducing gene that can cause selectively induced apoptosis in a population of diseased cells; entire classes of cells can be treated with one transfection
08/25/2005US20050187175 Methods and compositions for CPG15-2
08/25/2005US20050187161 peptide sequences that selectively bind to fungal surface molecules; Biopanning and Rapid Analysis of Selective Interactive Ligands (BRASIL) provides for rapid and efficient separation of phage that bind to fungal surface molecules
08/25/2005US20050187160 soluble proteins containing free cysteine residues and having increased efficiency
08/25/2005US20050187159 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability, therapy
08/25/2005US20050187158 comprises erythropoietin (EPO) and a pharmaceutically acceptable diluent, adjuvant, or carrier; to be applied locally and superficially; wound healing agents; alopecia; disease or disorder of the skin or the eye
08/25/2005US20050187156 Isozyme-specific antagonists of protein kinase C
08/25/2005US20050187155 For systematical, local or topical inhibition of metalloproteinases
08/25/2005US20050187152 Prevention and treatment of hypergastrinemia
08/25/2005US20050187151 administering polypeptide to target cells selected from bacteria, yeast and fungi, as antigrowth agents; peptide antibiotics
08/25/2005US20050187150 mimics the binding of heparin and heparan sulfate to the fibroblast growth factor (FGF) ligand and receptor; ternary complex of:an FGF ligand polypeptide; an FGF receptor polypeptide; and a heparin agonist or antagonist
08/25/2005US20050186677 Novel mutated mammalian cells and animals
08/25/2005US20050186675 Allelic series of genomic modifications in cells
08/25/2005US20050186665 Expressed ligand - vascular intercellular signaling molecule
08/25/2005US20050186664 Albumin fusion proteins
08/25/2005US20050186663 Cystine-knot fold protein
08/25/2005US20050186662 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders
08/25/2005US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis
08/25/2005US20050186658 Chimeric metabotropic glutamate receptors and uses thereof
08/25/2005US20050186657 Glycoprotein synthesis
08/25/2005US20050186656 Glycoprotein synthesis
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005US20050186649 Inhibitors of human plasmin derived from the kunitz domains
08/25/2005US20050186644 Contacting a sample comprising bladder cells taken from the subject with an antibody that specifically binds to nuclear matrix protein BLCA-4, wherein bladder cancer or risk of developing bladder cancer is indicated if sample contains nuclear matrix protein BLCA-4
08/25/2005US20050186641 immobilized poly(amino acids) are labeled or detected on blots or on arrays of poly(amino acids), or are attached to immobilized aptamers; use in analysis and diagnostics
08/25/2005US20050186639 Gene originating in human chondrocyte
08/25/2005US20050186638 Detecting modulators of brain membrane protein; obtained membrane protein incubated with ligand and labeled compound, measure level of binding
08/25/2005US20050186637 Hybridoma cell for use in propagation of immunoglobulins for treatment and prevention of autoimmune, pancreatic, blood and cell proliferative disorders
08/25/2005US20050186636 Using bone regulatory protein as tool in identifying modulators of bone mineral density
08/25/2005US20050186632 Comprises heavy metal sensitive DNA sequences; kits
08/25/2005US20050186628 Dorsalin-1 polypeptide and uses thereof
08/25/2005US20050186627 Cloned peripheral nerve, tetrodotoxin-resistant sodium channel alpha-subunit
08/25/2005US20050186626 Chicken leukemia inhibitory factor (LIF) and gene thereof
08/25/2005US20050186623 Recovering immunoglobulins from hybridoma cell line; bioreactor and heterologous gene expression
08/25/2005US20050186622 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
08/25/2005US20050186621 Using host cells to propagate preferential viral proteins for use in generating vaccines aganist microorganismal infection
08/25/2005US20050186620 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response
08/25/2005US20050186617 Transgenic cell comprising vitamin d3 receptor for use as gene expression diagnostic tool which monitor conversion of ligand precursors into ligands
08/25/2005US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/25/2005US20050186615 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding
08/25/2005US20050186613 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/25/2005US20050186612 Dendritic cell receptor
08/25/2005US20050186610 Tumor protein fusion for use in diagnosis, prevention and treatment of cell proliferative disorders
08/25/2005US20050186608 Therapeutic polypeptide recovered from mammalian milk for diagnosis, prevention and treatment of insulin resistance, cardiovascular and hypotensive disorders
08/25/2005US20050186603 Genetic engineering amino acid sequence comprising a replacements of Asn for Pro and Arg; biological conjugated drugs; cell line transfected by eukaryotic expression vector; culturing; biodrugs for anticancer therapy, bone marrow transplantation, platelet production in vivo
08/25/2005US20050186593 Cloning and recombinant production of CRF receptor(s)
08/25/2005US20050186575 Corona-virus-like particles comprising functionally deleted genomes
08/25/2005US20050186574 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders
08/25/2005US20050186569 Nucleic acid-associated proteins
08/25/2005US20050186563 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA
08/25/2005US20050186562 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time
08/25/2005US20050186560 Mammalian cell expressing viral replication protein for use as tool in identifying modulators for treatment of cell proliferative and autoimmune disorders; immunotherapy
08/25/2005US20050186266 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/25/2005US20050186224 Attenuated bovine respiratory syncytial virus
08/25/2005US20050186220 derived from canine distemper virus; vaccines for inducing immune response
08/25/2005US20050186219 Transgenic plant-based vaccines
08/25/2005US20050186218 From Moraxella catarrhalis outer membrane proteins; ultrafiltration
1 ... 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 ... 2916